Genomic Health Inc Revenue Growth Rates (GHDX), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Genomic Health Inc  (NASDAQ: GHDX)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

GHDX's Revenue Growth by Quarter and Year

Genomic Health Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GHDX Revenue (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
4th Quarter December -
3rd Quarter September 114.36
2nd Quarter June 114.14
1st Quarter March 108.77
FY 337.27

GHDXs Annual Revenue
Genomic Health Inc's Revenue in the fiscal year 2018 $ 394.11 millions
Genomic Health Inc's Revenue in the fiscal year 2017 $ 340.75 millions
Genomic Health Inc's Revenue in the fiscal year 2016 $ 327.87 millions
Genomic Health Inc's Revenue in the fiscal year 2015 $ 287.46 millions
Genomic Health Inc's Revenue in the fiscal year 2014 $ 275.71 millions




GHDX Revenue third quarter 2019 Y/Y Growth Comment
Genomic Health Inc achieved in the third quarter 2019, above Company average Revenue increase of 12.93% year on year, to $ 114.36 millions.

Looking into third quarter 2019 results within Medical Laboratories industry 14 other companies have achieved higher Revenue growth. While Genomic Health Inc' s Revenue growth of 12.93% ranks overall at the positon no. 1192 in the third quarter 2019.


GHDX Revenue ( Y/Y Growth %) 2019
 2018 2017 2016
4th Quarter December - 19.61 % 5.7 % 10.13 %
3rd Quarter September 12.93 % 20.81 % 1.9 % 11.84 %
2nd Quarter June 19.37 % 11.85 % 4.29 % 16.07 %
1st Quarter March 17.42 % 10.3 % 3.82 % 18.69 %
FY   - 15.66 % 3.93 % -

Financial Statements
Genomic Health Inc's third quarter 2019 Revenue $ 114.36 millions GHDX's Income Statement
Genomic Health Inc's third quarter 2018 Revenue $ 101.26 millions Quarterly GHDX's Income Statement


GHDX Revenue (Quarter on Quarter Growth %)

 2019
 2018 2017 2016
4th Quarter December - 3.31 % 4.34 % 0.58 %
3rd Quarter September 0.19 % 5.9 % -1.95 % 0.35 %
2nd Quarter June 4.94 % 3.23 % 1.8 % 1.34 %
1st Quarter March 3.98 % 5.91 % 1.5 % 7.67 %
FY (Year on Year)   - 15.66 % 3.93 % -


Back to GHDX Growth rate Comparisons >> Back to GHDX Growth rate Comparisons >>


Revenue third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #15
Healthcare Sector #226
Overall #1192

Revenue Y/Y Growth Statistics
High Average Low
21.25 % 10.23 % -5.65 %
(Dec 31 2013)   (Dec 31 2014)
Revenue third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #15
Healthcare Sector #226
Overall #1192
Revenue Y/Y Growth Statistics
High Average Low
21.25 % 10.23 % -5.65 %
(Dec 31 2013)   (Dec 31 2014)

Revenue by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Genomic Health Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
11.03 % 2.3 % -8.55 %
(Dec 31 2013)  


GHDX's III. Quarter Q/Q Revenue Comment
Genomic Health Inc achieved in the III. Quarter 2019 below company average Revenue growth of 0.19% quarter on quarter, to $ 114.36 millions.

Within Medical Laboratories industry 22 other companies have achieved higher Revenue quarter on quarter growth. While Genomic Health Inc's Revenue growth quarter on quarter, overall rank is 1944.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #23
Healthcare Sector #323
Overall #1944
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #23
Healthcare Sector #323
Overall #1944
Revenue Q/Q Growth Statistics
High Average Low
11.03 % 2.3 % -8.55 %
(Dec 31 2013)  


GHDX's III. Quarter Q/Q Revenue Comment
Genomic Health Inc achieved in the III. Quarter 2019 below company average Revenue growth of 0.19% quarter on quarter, to $ 114.36 millions.

Within Medical Laboratories industry 22 other companies have achieved higher Revenue quarter on quarter growth. While Genomic Health Inc's Revenue growth quarter on quarter, overall rank is 1944.


Genomic Health Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2019)		 12 Months Ending
(Jun 30 2019)		 12 Months Ending
(Mar 31 2019)		 12 Months Ending
(Dec 31 2018)		 12 Months Ending
(Sep 30 2018)
Cumulative Revenue 12 Months Ending $ 441.87 $ 428.78 $ 410.26 $ 394.11 $ 376.97
Y / Y Revenue Growth (TTM) 17.22 % 19.26 % 17.42 % 15.66 % 12.18 %
Year on Year Revenue Growth Overall Ranking # 920 # 579 # 815 # 711 # 1066
Seqeuential Revenue Change (TTM) 3.05 % 4.51 % 4.1 % 4.55 % 4.85 %
Seq. Revenue Growth (TTM) Overall Ranking # 937 # 585 # 840 # 595 # 931


Cumulative Revenue growth Comment
Assuming the Genomic Health Inc's fiscal year would have ended in Sep 30 2019, Genomic Health Inc would have reprted above average annual Revenue increase of 17.22% year on year, of $ 442 millions.
This marks a slow-down of the companys growth trends and from the 19.26% rise in Jun 30 2019.

In the Healthcare sector 188 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 579 to 920.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 18
Healthcare Sector # 189
Overall # 920

Revenue TTM Y/Y Growth Statistics
High Average Low
19.26 %
 9.58 %
0.1 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 18
Sector # 192
S&P 500 # 937
Cumulative Revenue growth Comment
Assuming the Genomic Health Inc's fiscal year would have ended in Sep 30 2019, Genomic Health Inc would have reprted above average annual Revenue increase of 17.22% year on year, of $ 442 millions.
This marks a slow-down of the companys growth trends and from the 19.26% rise in Jun 30 2019.

In the Healthcare sector 188 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 579 to 920.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 18
Healthcare Sector # 189
Overall # 920

Revenue TTM Y/Y Growth Statistics
High Average Low
19.26 %
9.58 %
0.1 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 18
Sector # 192
S&P 500 # 937




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
GHDX's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue rise for the quarter ending Sep 30 2019 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2019
Intuitive Surgical Inc 22.51%$ 22.511 millions
Valeritas Holdings Inc.22.19%$ 22.192 millions
Inspiremd Inc 22.11%$ 22.107 millions
Biocryst Pharmaceuticals Inc 22.08%$ 22.077 millions
The Pennant Group Inc 21.17%$ 21.171 millions
Vertex Pharmaceuticals Inc21.07%$ 21.069 millions
Vanda Pharmaceuticals Inc 21.06%$ 21.064 millions
Si bone inc 20.93%$ 20.933 millions
Radnet Inc 20.87%$ 20.873 millions
Pacific Biosciences Of California Inc 20.68%$ 20.677 millions
Edwards Lifesciences Corporation20.67%$ 20.671 millions
Medpace Holdings Inc 20.63%$ 20.633 millions
Precipio inc 20.62%$ 20.615 millions
Exelixis Inc 20.54%$ 20.544 millions
Catalent Inc 20.46%$ 20.460 millions
Lemaitre Vascular Inc 20.42%$ 20.422 millions
Viemed Healthcare Inc 20.31%$ 20.307 millions
Utah Medical Products Inc20.25%$ 20.250 millions
Align Technology inc 20.20%$ 20.197 millions
Icagen, Inc.19.66%$ 19.663 millions
Natera Inc 19.35%$ 19.346 millions
Avinger Inc 19.31%$ 19.307 millions
Misonix Inc 19.07%$ 19.066 millions
Surgalign Holdings Inc 18.89%$ 18.888 millions
Fonar Corporation18.86%$ 18.860 millions
Harrow Inc 18.77%$ 18.773 millions
American Shared Hospital Services18.59%$ 18.591 millions
Amedisys Inc18.53%$ 18.531 millions
Cumberland Pharmaceuticals Inc 18.48%$ 18.483 millions
Viewray Inc 18.09%$ 18.091 millions


About Genomic Health Inc Revenue Growth Rates (GHDX), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.